Eye Care - France

  • France
  • Revenue in the Eye Care market amounts to US$116.30m in 2024. The market is expected to grow annually by 1.90% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (US$1,256m in 2024).
  • In relation to total population figures, per person revenues of US$1.79 are generated in 2024.

Key regions: Canada, Thailand, Philippines, Worldwide, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Eye Care market in France is experiencing significant growth and development, driven by various factors such as changing customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Eye Care market in France have been shifting towards more advanced and innovative products.

Consumers are increasingly seeking out products that offer multiple benefits, such as contact lenses that not only correct vision but also provide UV protection and moisture retention. This trend is driven by a growing awareness of the importance of eye health and the desire for convenience in daily eye care routines. In addition to customer preferences, several market trends are shaping the development of the Eye Care market in France.

One major trend is the increasing prevalence of digital devices in everyday life. With the rise of smartphones, tablets, and computers, people are spending more time in front of screens, which can lead to eye strain and other vision-related issues. As a result, there is a growing demand for products that alleviate digital eye strain, such as specialized eyeglasses and eye drops.

Another trend in the Eye Care market in France is the growing popularity of natural and organic products. Consumers are becoming more conscious of the ingredients used in their eye care products and are seeking out options that are free from harmful chemicals and preservatives. This trend is driven by a broader shift towards natural and sustainable lifestyles, as well as concerns about potential side effects of traditional eye care products.

Local special circumstances also play a role in the development of the Eye Care market in France. The country has a well-established healthcare system, which includes regular eye exams and access to prescription eyewear. This has created a strong foundation for the market, as consumers are accustomed to seeking professional advice and investing in quality eye care products.

Additionally, France has a large aging population, which contributes to the demand for products that address age-related eye conditions, such as presbyopia and cataracts. Underlying macroeconomic factors further support the growth of the Eye Care market in France. The country has a stable economy and a high standard of living, which allows consumers to prioritize their eye health and invest in premium products.

Furthermore, advancements in technology and manufacturing processes have made eye care products more affordable and accessible to a wider range of consumers. In conclusion, the Eye Care market in France is experiencing growth and development due to changing customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. As consumers prioritize their eye health and seek out innovative and convenient products, the market is expected to continue expanding in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)